Protective Mechanism and Treatment of Neurogenesis in Cerebral Ischemia

Neurochem Res. 2020 Oct;45(10):2258-2277. doi: 10.1007/s11064-020-03092-1. Epub 2020 Aug 13.

Abstract

Stroke is the fifth leading cause of death worldwide and is a main cause of disability in adults. Neither currently marketed drugs nor commonly used treatments can promote nerve repair and neurogenesis after stroke, and the repair of neurons damaged by ischemia has become a research focus. This article reviews several possible mechanisms of stroke and neurogenesis and introduces novel neurogenic agents (fibroblast growth factors, brain-derived neurotrophic factor, purine nucleosides, resveratrol, S-nitrosoglutathione, osteopontin, etc.) as well as other treatments that have shown neuroprotective or neurogenesis-promoting effects.

Keywords: Cerebral ischemia; Fibroblast growth factors; Neurogenesis; Purine nucleosides; Resveratrol; S-nitrosoglutathione.

Publication types

  • Review

MeSH terms

  • Animals
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / etiology
  • Humans
  • Neurogenesis / drug effects*
  • Neurons / metabolism
  • Neuroprotective Agents / therapeutic use*
  • Signal Transduction / physiology
  • Stroke / drug therapy*
  • Stroke / etiology

Substances

  • Neuroprotective Agents